Observational Study Suggests Reduced Risk for Mortality and Hepatocellular Carcinoma in Patients with Hepatitis C Treated with Direct-acting Antivirals

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study – The Lancet (link to abstract – $ for full-text)

Commentaries: Direct-acting antivirals reduce risk of premature mortality and liver cancer for people with chronic hepatitis C – The Lancet (free) AND Hepatitis C: Study finds Direct Acting Antivirals Reduce Mortality and Liver Cancer – MedicalResearch.com (free)